Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Evercore ISI Group Maintains Outperform on Lyft, Lowers Price Target to $42

By Benzinga Newsdesk
July 7, 10:23 AM
Evercore ISI Group analyst Mark Mahaney maintains Lyft (NASDAQ:LYFT) with a Outperform and lowers the price target from $45 to $42.

LYFT

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Evercore ISI Group Maintains Outperform on Grab Hldgs, Lowers Price Target to $5

By Benzinga Newsdesk
July 7, 10:21 AM
Evercore ISI Group analyst Mark Mahaney maintains Grab Hldgs (NASDAQ:GRAB) with a Outperform and lowers the price target from $6 to $5.

GRAB

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks

Galmed’s Aramchol Shows Anti-Fibrotic Effects In Lung Fibrosis Animal Model

By Vandana Singh
July 7, 10:18 AM
Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) announced results showing significant effects of Aramchol in a preclinical lung and gastrointestinal (GI) fibrosis model. Treatment…

GLMD

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Evercore ISI Group Maintains In-Line on eBay, Lowers Price Target to $50

By Benzinga Newsdesk
July 7, 10:18 AM
Evercore ISI Group analyst Mark Mahaney maintains eBay (NASDAQ:EBAY) with a In-Line and lowers the price target from $59 to $50.

EBAY

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Evercore ISI Group Maintains Outperform on Booking Holdings, Lowers Price Target to $2600

By Benzinga Newsdesk
July 7, 10:16 AM
Evercore ISI Group analyst Mark Mahaney maintains Booking Holdings (NASDAQ:BKNG) with a Outperform and lowers the price target from $3000 to $2600.

BKNG

Read More
1 minute read
  • Cannabis
  • Markets
  • News

Health Advance Starts Production Of Its CBD Infused De-Alcoholized Wine Beverage

By Vuk Zdinjak
July 7, 10:13 AM
Health Advance, Inc.’s (OTCPK:HADV) new CBD infused de-alcoholized wine beverage is now in production. Allocation of the first manufacturing run of 19,400 units will be made among customers who are competing for early deliveries at the beginning of August.

HADV

Read More
1 minute read
  • Cryptocurrency
  • Markets
  • News
  • Penny Stocks

Kevin O’Leary: Why Bitcoin’s Crash, Voyager Collapse Are ‘Good Thing’ For Crypto

By Samyuktha Sriram
July 7, 10:13 AM
All the liquidation and bankruptcy events that followed the Bitcoin (CRYPTO: BTC) market downturn will prove to be healthy for the crypto market in the long run, according to Shark Tank investor Kevin O’Leary.

BTC

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Lake Street Maintains Buy on DiaMedica Therapeutics, Lowers Price Target to $8

By Benzinga Newsdesk
July 7, 10:12 AM
Lake Street analyst Thomas Flaten maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and lowers the price target from $14 to $8.

DMAC

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Craig-Hallum Maintains Buy on Aspen Aerogels, Lowers Price Target to $32

By Benzinga Newsdesk
July 7, 10:09 AM
Craig-Hallum analyst Eric Stine maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $50 to $32.

ASPN

Read More
2 minute read
  • Markets
  • Options

Check Out What Whales Are Doing With Micron Technology

By Benzinga Insights
July 7, 10:05 AM
Someone with a lot of money to spend has taken a bearish stance on Micron Technology (NASDAQ:MU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

MU

Posts pagination

Previous 1 … 18,971 18,972 18,973 … 19,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service